In the study conducted by Henning Reis et al., they concluded that CK20, havingan overall positive rate of 97%, and CK7 displayed a pooled reactivity rate of 51%, compared to considerably lower rates in colorectal cancer (0–38%) [71]. This evidence concerns the gene KRT7 and colorectal cancer.